The enrichment and activation of CD8+ TILs in BC are associated with improved treatment outcomes and prognosis.(4–6) Furthermore, using CD8+ TILs in adoptive cell therapy has shown efficacy against various cancers. The gene discussed is CD8A; the disease is cancer.